WNT7B and breast carcinoma: The highest frequency rate of “amplification” of WNT2, WNT7B, and WNT11 was recorded at 3.69%, 15.83%, and 33.25%, respectively, notably within The Metastatic Breast Cancer Project (Provisional, December 2021).